We and others identified KIF14 as an important oncogene, prognostic indicator, biomarker and therapeutic target in the progression of multiple cancers, including retinoblastoma, glioma, breast, lung, renal, hepatocellular and ovarian cancers [1], [4]–[9],[14],[29]–[32]]. Here, KIF14 is linked to ovarian carcinoma.